Measurement of cardiovascular disease biomarkers in human clinical samples using Luminex technologybased MILLIPLEX® MAP multiplex panels

Brought to you by:

First Name *

Last Name *

Email *

Phone Number *

Company *

Company Address *

City *

Country *

State/Province *

Postal Code *

Job Title *

Company Size

Industry *

Get the White Paper

FREE White Paper

Measurement of cardiovascular disease biomarkers in human clinical samples

Sponsored by EMD Millipore

Cardiovascular disease is the leading cause of mortality in the United States. As early diagnosis is critical, interest in measurement of CVD biomarkers has increased dramatically. CVD biomarker discovery research has focused on arterial plaque related disease as conditions are prevalent, chronic and progressive and can be measured by soluble biomarkers.

Thus we developed an assay, utilizing Luminex® xMAP® technology, that includes characteristic analytes for every cardiac disease stage. After rigorous assay validation, we tested serum and plasma samples from patients with and without diagnosed CVD, and found that many of the CVD biomarkers were significantly elevated in CVD patients, indicating the utility of the assay panels.

Privacy Policy

This data may be used by the sponsor to provide you with information within the scope of this white paper. Any information you submit by this form will only be used for the purposes indicated. You can trust Advantage Business Media not to rent, sell, exchange, or give your information to any third party without permission.